Extracellular space measurements with CMR imaging

JACC: Cardiovascular Imaging

Volumn 5, Issue 9, 2012, Pages 908-910

  Judd, Robert M ^a   Kim, Raymond J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

amyloid; infiltrative cardiomyopathy; left ventricular mass; MRI contrast agents; myocardial delayed enhancement; T1 mapping; viability

Indexed keywords

CONTRAST MEDIUM;

CARDIAC IMAGING; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL EFFECTIVENESS; CONTRAST ENHANCEMENT; DISEASE SEVERITY; EXTRACELLULAR SPACE; EXTRACELLULAR VOLUME FRACTION; HEART MUSCLE CELL; IMAGE ANALYSIS; IMAGE PROCESSING; MEASUREMENT; MOLECULE; MYOCARDIAL DISEASE; NOTE; PRIORITY JOURNAL; PROGNOSIS; RADIOLOGICAL PARAMETERS;

EID: 84866327175     PISSN: 1936878X     EISSN: 18767591     Source Type: Journal    
DOI: 10.1016/j.jcmg.2012.04.007     Document Type: Editorial

References (15)

1. H.W. Kim, A. Farzaneh-Far, R.J. Kim Cardiovascular magnetic resonance in patients with myocardial infarction: current and emerging applications J Am Coll Cardiol 55 2010 1 16
2. J. Schwitter, A.E. Arai Assessment of cardiac ischaemia and viability: role of cardiovascular magnetic resonance Eur Heart J 32 2011 799 809
3. R.J. Kim, E. Wu, A. Rafael The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction N Engl J Med 343 2000 1445 1453
4. M.G. Friedrich, U. Sechtem, J. Schulz-Menger Cardiovascular magnetic resonance in myocarditis: a JACC White Paper J Am Coll Cardiol 53 2009 1475 1487
5. H. Mahrholdt, A. Wagner, C.C. Deluigi Presentation, patterns of myocardial damage, and clinical course of viral myocarditis Circulation 114 2006 1581 1590
6. M.R. Patel, P.J. Cawley, J.F. Heitner Detection of myocardial damage in patients with sarcoidosis Circulation 120 2009 1969 1977
7. O. Bruder, A. Wagner, C.J. Jensen Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy J Am Coll Cardiol 56 2010 875 887
8. R. O'Hanlon, A. Grasso, M. Roughton Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy J Am Coll Cardiol 56 2010 867 874
9. B.Y. Cheong, R. Muthupillai, J.M. Wilson Prognostic significance of delayed-enhancement magnetic resonance imaging: survival of 857 patients with and without left ventricular dysfunction Circulation 120 2009 2069 2076
10. I. Klem, D.J. Shah, R.D. White Prognostic value of routine cardiac magnetic resonance assessment of left ventricular ejection fraction and myocardial damage: an international, multicenter study Circ Cardiovasc Imaging 4 2011 610 619
11. F.-P. Mongeon, M. Jerosch-Herold, O.R. Coelho-Filho, R. Blankstein, R.H. Falk, R.Y. Kwong Quantification of extracellular matrix expansion by CMR in infiltrative heart disease J Am Coll Cardiol Img 5 2012 897 907
12. M. Jerosch-Herold, D.C. Sheridan, J.D. Kushner Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy Am J Physiol Heart Circ Physiol 295 2008 H1234 H1242
13. Magnevist Package Insert, Bayer Response NDA 019596 Magnevist Inj 14 Dec 10 http://berlex.bayerhealthcare.com/html/products/pi/Magnevist-PI.pdf Accessed August 27, 2012
14. A.M. Maceira, J. Joshi, S.K. Prasad Cardiovascular magnetic resonance in cardiac amyloidosis Circulation 111 2005 186 193
15. D.R. Messroghli, A. Radjenovic, S. Kozerke, D.M. Higgins, M.U. Sivananthan, J.P. Ridgway Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart Magn Reson Med 52 2004 141 146